8918 Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: 0937–0191–60D] 

Agency Information Collection 

Request; 60-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. The ICR 

is for extending the use of the approved 

information collection assigned OMB 

control number 0937–0191, which 

expires on April 30, 2021. Prior to 

submitting the ICR to OMB, OS seeks 

comments from the public regarding the 

burden estimate, below, or any other 

aspect of the ICR. 

DATES: Comments on the ICR must be 

received on or before April 12, 2021. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202) 795–7714. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0937–0191– 

60D, and project title for reference, to 

Sherrette Funn, the Reports Clearance 

Officer, Sherrette.funn@hhs.gov, or call 

202–795–7714. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Application 

packets for Real Property for Public 

Health Purposes. 

Type of Collection: Extension. 

OMB No.: 0937–0191. 

Abstract: The Office of Assistant 

Secretary for Administration, Program 

Support Center, Federal Real Property 

Assistance Program is requesting OMB 

approval on a previously approved 

information collection, 0937–0191. 40 

U.S.C. 550 (the ‘‘Act’’), as amended, 

provides authority to the Secretary of 

Health and Human Services to convey 

or lease surplus real property to States 

and their political subdivisions and 

instrumentalities, to tax-supported 

institutions, and to nonprofit 

institutions which (except for 

institutions which lease property to 

assist the homeless) have been held 

exempt from taxation under Section 

501(c)(3) of the 1954 Internal Revenue 

Code, and 501(c)(19) for veterans 

organizations, for public health and 

homeless assistance purposes. Transfers 

are made to transferees at little or no 

cost. 

Type of respondent: Responses are 

dependent on when Federal surplus real 

property is made available and is 

desired by a respondent/applicant for 

acquisition. Likely respondents include 

State, local, or tribal units of 

government or instrumentalities thereof, 

and not-for-profit organizations. 

ANNUALIZED BURDEN HOUR TABLE

Forms 

(if necessary) 

Respondents 

(if necessary) 

Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

Total 

burden hours 

Applications for surplus Federal real property ..................... ........................ 15 1 200 3,000 

Total .............................................................................. ........................ 15 1 200 3,000 

Dated: January 19, 2021. 

Sherrette A. Funn, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 2021–02734 Filed 2–9–21; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary 

and Integrative Health; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Complementary and 

Integrative Health. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

The meeting will be held as a virtual 

meeting and is open to the public as 

indicated below. 

Individuals who plan to view the 

virtual meeting and need special 

assistance or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

The Open Session will be open to the 

public via NIH Videocast. The URL link 

to access this meeting is https://

videocast.nih.gov. 

Name of Committee: National Advisory 

Council for Complementary and Integrative 

Health. 

Date: May 14, 2021. 

Closed: 10:00 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Democracy 2, 6707 Democracy Boulevard, 

Bethesda, MD 20817, (Virtual Meeting). 

Open: 11:40 a.m. to 5:00 p.m. 

Agenda: A report from the Director of the 

Center and Other Staff. 

Place: National Institutes of Health, 

Democracy 2, 6707 Democracy Boulevard, 

Bethesda, MD 20817, (Virtual Meeting). 

Contact Person: Partap Singh Khalsa, 

Ph.D., DC, Director, Division of Extramural 

Activities, National Center for 

Complementary and Integrative Health, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 401, Bethesda, MD 

20892–5475, 301–594–3462, khalsap@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. Any 

member of the public may submit written 

comments no later than 15 days after the 

meeting. 

Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices 8919 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nccih.nih.gov/news/events/advisorycouncil-77th-meeting, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: February 4, 2021. 

Ronald J. Livingston, Jr., 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02718 Filed 2–9–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Genes, Genomes and Genetics. 

Date: March 2–3, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lystranne Alysia Maynard 

Smith, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, 301–402–4809, 

lystranne.maynard-smith@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery for Aging, 

Neuropsychiatric and Neurologic Disorders. 

Date: March 9–10, 2021. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Aurea D. De Sousa, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, Room 5186, Bethesda, MD 

20892, 301–827–6829, aurea.desousa@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biomaterials, Delivery, and 

Nanotechnology. 

Date: March 9–10, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nitsa Rosenzweig, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7760, Bethesda, MD 20892, (301) 404– 

7419, rosenzweign@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Musculoskeletal, Rehabilitation 

and Skin Sciences. 

Date: March 9–10, 2021. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Chi-Wing Chow, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4110, 

Bethesda, MD 20892, (301) 402–3912, 

chowc2@mail.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review Group; 

International and Cooperative Projects—1 

Study Section. 

Date: March 9–10, 2021. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Seetha Bhagavan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5194, 

MSC 7846, Bethesda, MD 20892, (301) 237– 

9838, bhagavas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Chemistry, Biochemistry and 

Biophysics. 

Date: March 9–10, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shan Wang, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6701 Rockledge Drive, 

Bethesda, MD 20892, (858) 735–0788, 

shan.wang@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–19– 

372: Social Epigenomics Research Focused 

on Minority Health and Health Disparities. 

Date: March 9, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Inna Gorshkova, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, (301) 435–1784, gorshkoi@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–19– 

264: Imaging, Biomarkers and Digital 

Pathomics for the Early Detection of 

Premetastatic Aggressive Cancer. 

Date: March 9, 2021. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ileana Hancu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5116, 

Bethesda, MD 20817, (301) 402–3911, 

ileana.hancu@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Receptors, Cell Cycle, Cytoskeleton 

and Membranes. 

Date: March 9, 2021. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Kevin Czaplinski, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, 6901 Rockledge Drive, 

Bethesda, MD 20892, (301) 480–9139, 

czaplinskik2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Tumor 

Biomarker and Therapy—Member Conflict. 

Date: March 9, 2021. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Ola Mae Zack Howard, 

Ph.D., BS, Scientific Review Officer, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7806, Bethesda, MD 20892, (301) 451– 

4467, howardz@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 4, 2021. 

Ronald J. Livingston, Jr., 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–02719 Filed 2–9–21; 8:45 am] 

BILLING CODE 4140–01–P